Related to many other eukaryotic palmitoyltransferases (e.g. mammalian ZDHHC4/9/14/24)
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 19 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 20 |
GO:0110165 | cellular anatomical entity | 1 | 20 |
GO:0005783 | endoplasmic reticulum | 5 | 2 |
GO:0005794 | Golgi apparatus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
Related structures:
AlphaFold database: A0A3Q8ICY2
Term | Name | Level | Count |
---|---|---|---|
GO:0006497 | protein lipidation | 5 | 2 |
GO:0006605 | protein targeting | 5 | 2 |
GO:0006612 | protein targeting to membrane | 5 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0006810 | transport | 3 | 2 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006897 | endocytosis | 5 | 1 |
GO:0008104 | protein localization | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018198 | peptidyl-cysteine modification | 6 | 2 |
GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 7 | 2 |
GO:0018231 | peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine | 7 | 2 |
GO:0018345 | protein palmitoylation | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043543 | protein acylation | 5 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0051668 | localization within membrane | 3 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0072657 | protein localization to membrane | 4 | 2 |
GO:0090150 | establishment of protein localization to membrane | 4 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 20 |
GO:0016409 | palmitoyltransferase activity | 5 | 20 |
GO:0016417 | S-acyltransferase activity | 5 | 20 |
GO:0016740 | transferase activity | 2 | 20 |
GO:0016746 | acyltransferase activity | 3 | 20 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 20 |
GO:0019706 | protein-cysteine S-palmitoyltransferase activity | 4 | 20 |
GO:0019707 | protein-cysteine S-acyltransferase activity | 3 | 20 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 20 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 339 | 343 | PF00656 | 0.491 |
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.387 |
CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.206 |
CLV_NRD_NRD_1 | 261 | 263 | PF00675 | 0.512 |
CLV_NRD_NRD_1 | 307 | 309 | PF00675 | 0.210 |
CLV_NRD_NRD_1 | 311 | 313 | PF00675 | 0.210 |
CLV_NRD_NRD_1 | 324 | 326 | PF00675 | 0.314 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.304 |
CLV_PCSK_FUR_1 | 148 | 152 | PF00082 | 0.350 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.387 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.208 |
CLV_PCSK_KEX2_1 | 261 | 263 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 307 | 309 | PF00082 | 0.211 |
CLV_PCSK_KEX2_1 | 324 | 326 | PF00082 | 0.378 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.335 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.229 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.472 |
CLV_PCSK_SKI1_1 | 331 | 335 | PF00082 | 0.384 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.421 |
DEG_APCC_DBOX_1 | 76 | 84 | PF00400 | 0.468 |
DEG_SCF_FBW7_1 | 249 | 256 | PF00400 | 0.195 |
DEG_SCF_FBW7_2 | 235 | 241 | PF00400 | 0.189 |
DOC_ANK_TNKS_1 | 15 | 22 | PF00023 | 0.588 |
DOC_CKS1_1 | 235 | 240 | PF01111 | 0.211 |
DOC_CKS1_1 | 250 | 255 | PF01111 | 0.200 |
DOC_CYCLIN_RxL_1 | 226 | 234 | PF00134 | 0.373 |
DOC_CYCLIN_RxL_1 | 45 | 57 | PF00134 | 0.529 |
DOC_MAPK_gen_1 | 204 | 213 | PF00069 | 0.404 |
DOC_MAPK_gen_1 | 312 | 319 | PF00069 | 0.656 |
DOC_MAPK_gen_1 | 45 | 53 | PF00069 | 0.539 |
DOC_MAPK_gen_1 | 76 | 85 | PF00069 | 0.602 |
DOC_MAPK_JIP1_4 | 47 | 53 | PF00069 | 0.543 |
DOC_MAPK_MEF2A_6 | 312 | 321 | PF00069 | 0.540 |
DOC_MAPK_MEF2A_6 | 78 | 87 | PF00069 | 0.429 |
DOC_PP1_RVXF_1 | 202 | 209 | PF00149 | 0.419 |
DOC_PP1_RVXF_1 | 47 | 54 | PF00149 | 0.535 |
DOC_PP1_RVXF_1 | 82 | 88 | PF00149 | 0.530 |
DOC_PP2B_LxvP_1 | 334 | 337 | PF13499 | 0.576 |
DOC_USP7_UBL2_3 | 45 | 49 | PF12436 | 0.687 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.301 |
DOC_WW_Pin1_4 | 249 | 254 | PF00397 | 0.283 |
DOC_WW_Pin1_4 | 332 | 337 | PF00397 | 0.600 |
DOC_WW_Pin1_4 | 40 | 45 | PF00397 | 0.690 |
LIG_14-3-3_CanoR_1 | 207 | 212 | PF00244 | 0.434 |
LIG_14-3-3_CanoR_1 | 261 | 265 | PF00244 | 0.360 |
LIG_14-3-3_CanoR_1 | 28 | 36 | PF00244 | 0.729 |
LIG_14-3-3_CanoR_1 | 312 | 318 | PF00244 | 0.640 |
LIG_Actin_WH2_2 | 134 | 152 | PF00022 | 0.312 |
LIG_AP2alpha_1 | 232 | 236 | PF02296 | 0.200 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.576 |
LIG_BIR_III_4 | 18 | 22 | PF00653 | 0.591 |
LIG_BRCT_BRCA1_1 | 87 | 91 | PF00533 | 0.544 |
LIG_eIF4E_1 | 121 | 127 | PF01652 | 0.305 |
LIG_eIF4E_1 | 230 | 236 | PF01652 | 0.222 |
LIG_FHA_1 | 136 | 142 | PF00498 | 0.401 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.345 |
LIG_FHA_1 | 99 | 105 | PF00498 | 0.255 |
LIG_FHA_2 | 137 | 143 | PF00498 | 0.375 |
LIG_FHA_2 | 304 | 310 | PF00498 | 0.437 |
LIG_GBD_Chelix_1 | 274 | 282 | PF00786 | 0.479 |
LIG_GBD_Chelix_1 | 285 | 293 | PF00786 | 0.289 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.268 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.285 |
LIG_LIR_Nem_3 | 228 | 233 | PF02991 | 0.322 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.607 |
LIG_LYPXL_S_1 | 145 | 149 | PF13949 | 0.247 |
LIG_LYPXL_yS_3 | 146 | 149 | PF13949 | 0.452 |
LIG_LYPXL_yS_3 | 254 | 257 | PF13949 | 0.200 |
LIG_MYND_1 | 40 | 44 | PF01753 | 0.550 |
LIG_NRBOX | 277 | 283 | PF00104 | 0.376 |
LIG_NRBOX | 316 | 322 | PF00104 | 0.514 |
LIG_PDZ_Class_1 | 350 | 355 | PF00595 | 0.649 |
LIG_Pex14_1 | 208 | 212 | PF04695 | 0.232 |
LIG_Pex14_1 | 226 | 230 | PF04695 | 0.259 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.280 |
LIG_Pex14_2 | 232 | 236 | PF04695 | 0.296 |
LIG_Pex14_2 | 87 | 91 | PF04695 | 0.483 |
LIG_SH2_STAT5 | 121 | 124 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.229 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.352 |
LIG_SH2_STAT5 | 297 | 300 | PF00017 | 0.289 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.484 |
LIG_SH3_2 | 23 | 28 | PF14604 | 0.608 |
LIG_SH3_3 | 17 | 23 | PF00018 | 0.589 |
LIG_SH3_3 | 330 | 336 | PF00018 | 0.497 |
LIG_SH3_4 | 45 | 52 | PF00018 | 0.677 |
LIG_SUMO_SIM_anti_2 | 101 | 107 | PF11976 | 0.290 |
LIG_SUMO_SIM_anti_2 | 283 | 289 | PF11976 | 0.287 |
LIG_SUMO_SIM_par_1 | 124 | 131 | PF11976 | 0.364 |
LIG_SUMO_SIM_par_1 | 277 | 283 | PF11976 | 0.332 |
LIG_TRAF2_1 | 347 | 350 | PF00917 | 0.578 |
LIG_UBA3_1 | 80 | 84 | PF00899 | 0.472 |
LIG_WRC_WIRS_1 | 72 | 77 | PF05994 | 0.423 |
LIG_WW_3 | 173 | 177 | PF00397 | 0.465 |
MOD_CDK_SPK_2 | 40 | 45 | PF00069 | 0.581 |
MOD_CDK_SPxxK_3 | 40 | 47 | PF00069 | 0.593 |
MOD_CK1_1 | 215 | 221 | PF00069 | 0.273 |
MOD_CK1_1 | 24 | 30 | PF00069 | 0.719 |
MOD_CK1_1 | 303 | 309 | PF00069 | 0.444 |
MOD_CK2_1 | 303 | 309 | PF00069 | 0.453 |
MOD_Cter_Amidation | 259 | 262 | PF01082 | 0.509 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.491 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.534 |
MOD_GlcNHglycan | 67 | 70 | PF01048 | 0.424 |
MOD_GlcNHglycan | 87 | 90 | PF01048 | 0.200 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.274 |
MOD_GSK3_1 | 212 | 219 | PF00069 | 0.348 |
MOD_GSK3_1 | 249 | 256 | PF00069 | 0.265 |
MOD_GSK3_1 | 298 | 305 | PF00069 | 0.302 |
MOD_GSK3_1 | 332 | 339 | PF00069 | 0.511 |
MOD_N-GLC_1 | 242 | 247 | PF02516 | 0.446 |
MOD_N-GLC_2 | 184 | 186 | PF02516 | 0.227 |
MOD_NEK2_1 | 127 | 132 | PF00069 | 0.304 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.281 |
MOD_NEK2_1 | 298 | 303 | PF00069 | 0.307 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.400 |
MOD_NEK2_2 | 71 | 76 | PF00069 | 0.496 |
MOD_PKA_1 | 307 | 313 | PF00069 | 0.443 |
MOD_PKA_2 | 260 | 266 | PF00069 | 0.289 |
MOD_PKA_2 | 27 | 33 | PF00069 | 0.736 |
MOD_PKA_2 | 307 | 313 | PF00069 | 0.470 |
MOD_PKB_1 | 63 | 71 | PF00069 | 0.434 |
MOD_Plk_1 | 349 | 355 | PF00069 | 0.544 |
MOD_Plk_4 | 192 | 198 | PF00069 | 0.509 |
MOD_Plk_4 | 217 | 223 | PF00069 | 0.421 |
MOD_Plk_4 | 336 | 342 | PF00069 | 0.470 |
MOD_Plk_4 | 56 | 62 | PF00069 | 0.534 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.301 |
MOD_ProDKin_1 | 249 | 255 | PF00069 | 0.293 |
MOD_ProDKin_1 | 332 | 338 | PF00069 | 0.604 |
MOD_ProDKin_1 | 40 | 46 | PF00069 | 0.690 |
TRG_DiLeu_BaEn_1 | 350 | 355 | PF01217 | 0.593 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.451 |
TRG_ENDOCYTIC_2 | 233 | 236 | PF00928 | 0.316 |
TRG_ENDOCYTIC_2 | 254 | 257 | PF00928 | 0.332 |
TRG_ENDOCYTIC_2 | 297 | 300 | PF00928 | 0.278 |
TRG_ER_diArg_1 | 147 | 150 | PF00400 | 0.498 |
TRG_ER_diArg_1 | 171 | 173 | PF00400 | 0.406 |
TRG_ER_diArg_1 | 323 | 325 | PF00400 | 0.612 |
TRG_ER_diArg_1 | 62 | 65 | PF00400 | 0.628 |
TRG_ER_diArg_1 | 75 | 78 | PF00400 | 0.592 |
TRG_Pf-PMV_PEXEL_1 | 229 | 234 | PF00026 | 0.447 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P729 | Leptomonas seymouri | 34% | 100% |
A0A0N1HZ19 | Leptomonas seymouri | 64% | 100% |
A0A0N1IMN2 | Leptomonas seymouri | 25% | 81% |
A0A0S4IT15 | Bodo saltans | 38% | 100% |
A0A0S4IXZ6 | Bodo saltans | 29% | 100% |
A0A0S4JRL4 | Bodo saltans | 38% | 99% |
A0A1X0NX08 | Trypanosomatidae | 41% | 100% |
A0A1X0NY30 | Trypanosomatidae | 26% | 100% |
A0A3Q8IIC8 | Leishmania donovani | 28% | 100% |
A0A3R7N519 | Trypanosoma rangeli | 39% | 100% |
A0A3S7WZD9 | Leishmania donovani | 20% | 100% |
A4HG63 | Leishmania braziliensis | 71% | 100% |
A4HMS9 | Leishmania braziliensis | 31% | 100% |
A4I1S8 | Leishmania infantum | 20% | 100% |
A4I395 | Leishmania infantum | 99% | 100% |
A4IBG8 | Leishmania infantum | 28% | 100% |
B3DN87 | Arabidopsis thaliana | 27% | 100% |
D0A7S1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9AF82 | Leishmania major | 28% | 100% |
E9AZI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
E9B6D8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
O74384 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 24% | 100% |
O80685 | Arabidopsis thaliana | 26% | 86% |
Q0WQK2 | Arabidopsis thaliana | 25% | 80% |
Q4Q8P8 | Leishmania major | 92% | 100% |
Q4Q9K8 | Leishmania major | 23% | 100% |
Q5PNZ1 | Arabidopsis thaliana | 26% | 86% |
Q5REH2 | Pongo abelii | 25% | 86% |
Q6CUB5 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 26% | 94% |
Q8VYS8 | Arabidopsis thaliana | 23% | 87% |
Q9CPV7 | Mus musculus | 26% | 86% |
Q9FLM3 | Arabidopsis thaliana | 26% | 87% |
Q9H6R6 | Homo sapiens | 25% | 86% |
Q9NXF8 | Homo sapiens | 22% | 100% |
Q9NYG2 | Homo sapiens | 23% | 100% |
Q9SB58 | Arabidopsis thaliana | 23% | 87% |
V5BC02 | Trypanosoma cruzi | 42% | 100% |